Manddo competitors

Manddo's competitors include ViewRay, Intersect ENT, SteadyMed Therapeutics and K2M Group
Add company...
Manddo
Manddo provides medical services.
ViewRay
ViewRay is a medical device company focused on developing a simultaneous MRI-guided adaptive radiation therapy technology for the treatment of cancer.
Intersect ENT
Intersect ENT provides therapy solutions that enable ENT physicians to improve the quality of life of patients.
SteadyMed Therapeutics
SteadyMed is a media-device company developing injectable therapeutic drugs for pain relief, diabetes and other chronic conditions.
K2M Group
K2M Group is a medical device company focused on treating some of the most difficult & challenging spinal pathologies.
Founding Date
Founding Date
N/A
Founding Date
2004
Founding Date
2003
Founding Date
2005
Founding Date
2004
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Gurugram, IN HQ
Locations
Oakwood Village, US HQ
Cleveland, US
Mountain View, US
Mountain View, US
Locations
Menlo Park, US HQ
Locations
San Ramon, US HQ
Rehovot, IL
Locations
Leesburg, US HQ
Rosenheim, DE
Uxbridge , GB
Employees
Employees
N/A
Employees
106
Employees
303
Employees
2812% increase
Employees
457
Valuation ($)
Valuation ($)
N/A
Valuation ($)
693 m
Valuation ($)
1 b
Valuation ($)
119.6 m
Valuation ($)
954.3 m
Facebook likes
Facebook likes
N/A
Facebook likes
934
Facebook likes
555
Facebook likes
N/A
Facebook likes
1.2 k
Twitter followers
Twitter followers
2.8 k
Twitter followers
698
Twitter followers
783
Twitter followers
77
Twitter followers
1.4 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$34m (FY, 2017)
Revenue (est.)
$96.3m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$258m (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
$27.7m (FY, 2017)
Cost of goods
$15.5m (FY, 2017)
Cost of goods
N/A
Cost of goods
$88.6m (FY, 2017)
Gross profit
Gross profit
N/A
Gross profit
$6.3m (FY, 2017)
Gross profit
$80.8m (FY, 2017)
Gross profit
N/A
Gross profit
$169.4m (FY, 2017)
Net income
Net income
N/A
Net income
N/A
Net income
($16.4m) (FY, 2017)
Net income
$25.9m (FY, 2016)
Net income
($37.1m) (FY, 2017)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
19 (FY, 2016)
Patents (US)
30 (FY, 2016)
Patents (US)
N/A
Patents (US)
N/A
Patents Issued
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
77 (FY, 2016)
Patents Issued
N/A
Patents Issued
415 (FY, 2016)
Patents Pending
Patents Pending
N/A
Patents Pending
108 (FY, 2016)
Patents Pending
37 (FY, 2016)
Patents Pending
N/A
Patents Pending
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 96.7m
Total funding raised
$ 102.9m
Total funding raised
$ 35m
Total funding raised
$ 40m
For sources of this data, please see the company profileDownload Excel

View company profiles

ViewRay
HQ
Oakwood Village, US
Employees
106

ViewRay is a medical device company focused on developing a simultaneous MRI-guided adaptive radiation therapy technology for the treatment of cancer.

View company
Intersect ENT
HQ
Menlo Park, US
Employees
303

Intersect ENT provides therapy solutions that enable ENT physicians to improve the quality of life of patients.

View company
SteadyMed Therapeutics
HQ
San Ramon, US
Employees
28↑ 12% increase

SteadyMed is a media-device company developing injectable therapeutic drugs for pain relief, diabetes and other chronic conditions.

View company
K2M Group
HQ
Leesburg, US
Employees
457

K2M Group is a medical device company focused on treating some of the most difficult & challenging spinal pathologies.

View company